articleThe LancetApr 29, 2016Closed access

Dupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium-to-high-dose inhaled corticosteroids plus a long-acting β2 agonist: a randomised double-blind placebo-controlled pivotal phase 2b dose-ranging trial

University of Pittsburgh · Washington University in St. Louis · +4 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

875
total citations
FWCI
79.62
Percentile
100%
References
30
Citations per year

Authors

16

Topics & keywords

Keywords
  • Medicine
  • Benralizumab
  • Dupilumab
  • Placebo
  • Asthma
  • Clinical endpoint
  • Adverse effect
  • Internal medicine
No related works found for this paper.

Funding